Anzeige
Mehr »
Donnerstag, 08.01.2026 - Börsentäglich über 12.000 News
Steht diese NASDAQ-Biotech-Aktie jetzt vor einer seltenen Kaufgelegenheit?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A40MSS | ISIN: CA46125T1093 | Ticker-Symbol: IUI
Frankfurt
08.01.26 | 08:08
18,900 Euro
-1,05 % -0,200
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
INTUITIVE SURGICAL INC CDR Chart 1 Jahr
5-Tage-Chart
INTUITIVE SURGICAL INC CDR 5-Tage-Chart

Aktueller Chart INTUITIVE SURGICAL INC CDR Aktie

Chart vergleichen mit:

Firmenname, WKN, ISIN oder Aktien-Kürzel

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%
Chart-Typ:
Zeitraum:
 
INTUITIVE SURGICAL INC CDR-Investoren interessieren sich auch für diese Wertpapiere
S&P Dow Jones Indices: BrightSpring Health Services Set to Join S&P SmallCap 600NEW YORK, Oct. 14, 2025 /PRNewswire/ -- BrightSpring Health Services Inc. (NASD: BTSG) will replace Veritex Holdings Inc. (NASD: VBTX) in the S&P SmallCap 600 effective...
► Artikel lesen
Progyny, Inc. Announces Third Quarter 2025 ResultsReports Revenue of $313.3 Million, Reflecting 9.3% GrowthRaises Full Year Guidance to Reflect Continued Strength in Member EngagementSelling Season Yields Over 80 New Clients, 900,000 New Lives, and...
► Artikel lesen
Progyny, Inc.: Progyny Expands Global Benefits to Include Pregnancy, Postpartum, and MenopauseGlobal employers can now empower their workforces with comprehensive women's health benefits, supported by localized expertiseNEW YORK, Oct. 22, 2025. (Nasdaq: PGNY), a global leader in women's health...
► Artikel lesen
Progyny, Inc. Announces Second Quarter 2025 ResultsReports Record Revenue of $332.9 Million, Reflecting 9.5% GrowthGenerates $55.5 Million in Quarterly Operating Cash Flow and Record $105.3 Million over the First Half of 2025 Raises Full Year Guidance...
► Artikel lesen
Privia Health Group, Inc.: Privia Health Reports Third Quarter 2025 Financial ResultsVery Strong Third Quarter and Year-to-Date Performance Across the BusinessNet Income +94.1% and Adjusted EBITDA +61.6% compared to 3Q'24Implemented Providers +13.1% and Practice Collections +27.1%...
► Artikel lesen
Privia Health Group, Inc.: Privia Health Reports Second Quarter 2025 Financial ResultsVery Strong First Half Performance Across All Key Operating and Financial MetricsImplemented Providers +13.8% and Practice Collections +18.5% compared to 2Q'24Guidance Raised to Above High End of...
► Artikel lesen